Back to top
more

DexCom (DXCM)

(Delayed Data from NSDQ)

$69.00 USD

69.00
3,405,133

-0.70 (-1.00%)

Updated Nov 5, 2024 04:00 PM ET

After-Market: $68.91 -0.09 (-0.13%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (86 out of 250)

Industry: Medical - Instruments

Zacks News

Here's Why DexCom (DXCM) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

DexCom (DXCM) to Launch Latest CGM System G7 in Canada

DexCom's (DXCM) G7 CGM System (launched in Canada) is expected to combine simplicity and power, thereby providing a better way to manage diabetes.

DexCom (DXCM) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, DexCom (DXCM) closed at $94.55, marking a +1.34% move from the previous day.

Benjamin Rains headshot

Buy this Tech Stock on the Dip in October for 50% Upside?

DXCM stock is currently down over 40% from its 2021 highs and trading 51% below its average Zacks price target even though it stands out in the connected health world that's likely to become standard medical practice.

Dynatronics Corporation (DYNT) Reports Q4 Loss, Tops Revenue Estimates

Dynatronics Corporation (DYNT) delivered earnings and revenue surprises of -85.29% and 5.02%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

DexCom (DXCM) Partners With RxFood for Automated Dietary Monitoring

DexCom's (DXCM) CGM systems will make dietary assessment through AI-enabled RxFood app, which automatically interprets food images for calorie count in Canada.

Should Vanguard Mid-Cap Growth ETF (VOT) Be on Your Investing Radar?

Style Box ETF report for VOT

DexCom (DXCM) Dips More Than Broader Markets: What You Should Know

DexCom (DXCM) closed at $94.16 in the latest trading session, marking a -1.19% move from the prior day.

Should Vanguard Mid-Cap ETF (VO) Be on Your Investing Radar?

Style Box ETF report for VO

DexCom (DXCM) Launches Latest CGM Sensor ONE in France

DexCom's (DXCM) latest CGM sensor, DexCom ONE, secures reimbursement coverage in France, bringing the real-time CGM sensor to half a million diabetes patients in the country.

Here's Why You Should Retain DexCom (DXCM) Stock for Now

DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.

DexCom (DXCM) Outpaces Stock Market Gains: What You Should Know

DexCom (DXCM) closed the most recent trading day at $105.22, moving +0.34% from the previous trading session.

DexCom (DXCM) Rises 7% in One Week: What's Driving It?

DexCom's (DXCM) shares have rallied nearly 7% over the past week, presumably on positive outlook for its CGM devices amid rising competition.

DexCom (DXCM) Dips More Than Broader Markets: What You Should Know

DexCom (DXCM) closed the most recent trading day at $104.91, moving -1.84% from the previous trading session.

Strength Seen in DexCom (DXCM): Can Its 6.5% Jump Turn into More Strength?

DexCom (DXCM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Why DexCom (DXCM) is a Top Growth Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

DexCom's (DXCM) G6 CGM Connects With Omnipod 5 AID in Germany

DexCom's (DXCM) G6 CGM system and Omnipod 5 AID system can now simplify diabetes management and improve health outcomes in Germany.

DexCom (DXCM) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, DexCom (DXCM) closed at $101.90, marking a +0.91% move from the previous day.

Is Trending Stock DexCom, Inc. (DXCM) a Buy Now?

Recently, Zacks.com users have been paying close attention to DexCom (DXCM). This makes it worthwhile to examine what the stock has in store.

Should iShares Russell Mid-Cap Growth ETF (IWP) Be on Your Investing Radar?

Style Box ETF report for IWP

Here's Why You Should Invest in Edward Lifesciences (EW) Now

Investors continue to be optimistic about Edward Lifesciences (EW) on the strength of a solid foundation for innovative therapies.

Myriad Genetics (MYGN) Adds ARR to Prolaris Biomarker Test

Myriad Genetics (MYGN) announces the integration of ARR into the Prolaris prostate cancer prognostic test.

Is Caribou Biosciences (CRBU) Stock Outpacing Its Medical Peers This Year?

Here is how Caribou Biosciences, Inc. (CRBU) and DexCom (DXCM) have performed compared to their sector so far this year.

Abbott (ABT) EPD Arm Grows, Low Testing Sales Play Spoilsport

Banking on the successful execution of Abbott's (ABT) branded generic operating model, EPD is well positioned for sustained growth in many of the growing pharmaceutical markets.

Reasons to Retain Quest Diagnostics (DGX) Stock for Now

Investors are optimistic about Quest Diagnostics (DGX) on the strength of the base business performance and acquisitions.